{"count": 9, "results": [{"_id": "40421425", "pmid": 40421425, "title": "Protective effects of apricot kernel oil and metformin against BPA-induced ovarian toxicity in rat models of polycystic ovary syndrome: insights into PI3K/AKT and mitochondrial apoptosis pathways.", "journal": "Toxicol Res (Camb)", "authors": ["Jiao X", "Zhang Q", "Ye G", "Xing F", "Xie D", "Wang L"], "date": "2025-05-25T00:00:00Z", "doi": "10.1093/toxres/tfaf071", "meta_date_publication": "2025 Jun", "meta_volume": "14", "meta_issue": "3", "meta_pages": "tfaf071", "score": 50248.11, "text_hl": "The results demonstrated that AKO, in synergy with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@, modulated hormone levels, reduced pro-@<m>DISEASE_Cytokine_Release_Syndrome</m> @DISEASE_MESH:D000080424 @@@inflammatory cytokines@@@, and enhanced antioxidant properties. ", "citations": {"NLM": "Jiao X, Zhang Q, Ye G, Xing F, Xie D, Wang L. Protective effects of apricot kernel oil and metformin against BPA-induced ovarian toxicity in rat models of polycystic ovary syndrome: insights into PI3K/AKT and mitochondrial apoptosis pathways. Toxicol Res (Camb). 2025 Jun;14(3):tfaf071. PMID: 40421425", "BibTeX": "@article{40421425, title={Protective effects of apricot kernel oil and metformin against BPA-induced ovarian toxicity in rat models of polycystic ovary syndrome: insights into PI3K/AKT and mitochondrial apoptosis pathways.}, author={Jiao X and Zhang Q and Ye G and Xing F and Xie D and Wang L}, journal={Toxicol Res (Camb)}, volume={14}, number={3}, pages={tfaf071}}"}}, {"_id": "37967593", "pmid": 37967593, "title": "Metformin attenuates inflammation and boosts autophagy in the liver and intestine of chronologically aged rats.", "journal": "Exp Gerontol", "authors": ["Kuai Z", "Chao X", "He Y", "Ren W"], "date": "2023-11-15T00:00:00Z", "doi": "10.1016/j.exger.2023.112331", "meta_date_publication": "2023 Nov 15", "meta_volume": "184", "meta_issue": "", "meta_pages": "112331", "score": 50247.32, "text_hl": "RESULTS: Short-term @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ pretreatment (31 days) in naturally aging rats (29 months old) increased autophagy levels and down-regulated the expression of various pro-@<m>DISEASE_Cytokine_Release_Syndrome</m> @DISEASE_MESH:D000080424 @@@inflammatory cytokines@@@ (@GENE_IL1B @GENE_24494 @@@IL-1beta@@@, @GENE_TNF @GENE_24835 @@@TNF-alpha@@@, @GENE_MMP9 @GENE_81687 @@@MMP-9@@@, and @GENE_IL6 @GENE_24498 @@@IL-6@@@) in various intestinal segments and the liver-the expression of @GENE_MAP1LC3A @GENE_362245 @@@LC3II@@@ protein enriched with the increase of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ concentration. ", "citations": {"NLM": "Kuai Z, Chao X, He Y, Ren W. Metformin attenuates inflammation and boosts autophagy in the liver and intestine of chronologically aged rats. Exp Gerontol. 2023 Nov 15;184():112331. PMID: 37967593", "BibTeX": "@article{37967593, title={Metformin attenuates inflammation and boosts autophagy in the liver and intestine of chronologically aged rats.}, author={Kuai Z and Chao X and He Y and Ren W}, journal={Exp Gerontol}, volume={184}, pages={112331}}"}}, {"_id": "32463794", "pmid": 32463794, "pmcid": "PMC7288975", "title": "Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19", "journal": "Aging (Albany NY)", "authors": ["Menendez JA"], "date": "2020-05-27T00:00:00Z", "doi": "10.18632/aging.103347", "meta_date_publication": "2020 May 27", "meta_volume": "12", "meta_issue": "10", "meta_pages": "8760-8765", "score": 50244.555, "text_hl": "The incorporation of @DISEASE_Infections @DISEASE_MESH:D007239 @@@infection@@@ rates, severity and lethality of @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@SARS-CoV-2 infections@@@ as new outcomes of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ usage in elderly populations at risk of developing severe @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@, together with the assessment of bronchial/serological titers of @<m>DISEASE_Cytokine_Release_Syndrome</m> @DISEASE_MESH:D000080424 @@@inflammatory cytokines@@@ and D-dimers, could provide a novel mechanistic basis for the consideration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a therapeutic strategy against the @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ and @DISEASE_Thrombosis @DISEASE_MESH:D013927 @@@thrombotic@@@ states underlying the gerolavic traits of @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@SARS-CoV-2 infection@@@.", "citations": {"NLM": "Menendez JA. Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19 Aging (Albany NY). 2020 May 27;12(10):8760-8765. PMID: 32463794", "BibTeX": "@article{32463794, title={Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19}, author={Menendez JA}, journal={Aging (Albany NY)}, volume={12}, number={10}, pages={8760-8765}}"}}, {"_id": "37773574", "pmid": 37773574, "title": "Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers.", "journal": "Inflammopharmacology", "authors": ["Petakh P", "Kamyshna I", "Kamyshnyi A"], "date": "2023-09-29T00:00:00Z", "doi": "10.1007/s10787-023-01341-7", "meta_date_publication": "2023 Sep 29", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50243.76, "text_hl": "@GENE_INS @GENE_3630 @@@Insulin@@@ therapy, a common treatment for @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D@@@ patients, has been linked to increased mortality in @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@ patients with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D.@@@ However, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, an anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ medication, has been shown to have anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ properties that may mitigate the @<m>DISEASE_Cytokine_Release_Syndrome</m> @DISEASE_MESH:D000080424 @@@cytokine@@@ storm observed in severe @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@ cases. ", "citations": {"NLM": "Petakh P, Kamyshna I, Kamyshnyi A. Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers. Inflammopharmacology. 2023 Sep 29;():. PMID: 37773574", "BibTeX": "@article{37773574, title={Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers.}, author={Petakh P and Kamyshna I and Kamyshnyi A}, journal={Inflammopharmacology}}"}}, {"_id": "35164292", "pmid": 35164292, "pmcid": "PMC8839105", "title": "Nanoparticles of Costus speciosus Ameliorate Diabetes-Induced Structural Changes in Rat Prostate through Mediating the Pro-Inflammatory Cytokines IL 6, IL1beta and TNF-alpha", "journal": "Molecules", "authors": ["Bakhshwin D", "Faddladdeen KAJ", "Ali SS", "Alsaggaf SM", "Ayuob NN"], "date": "2022-02-02T00:00:00Z", "doi": "10.3390/molecules27031027", "meta_date_publication": "2022 Feb 2", "meta_volume": "27", "meta_issue": "3", "meta_pages": "", "score": 50241.887, "text_hl": "Prostatic expression of the mRNA of pro-@<m>DISEASE_Cytokine_Release_Syndrome</m> @DISEASE_MESH:D000080424 @@@inflammatory cytokines@@@ @GENE_IL6 @GENE_24498 @@@IL-6@@@, @GENE_IL1B @GENE_24494 @@@IL1beta@@@ and @GENE_TNF @GENE_24835 @@@TNF-alpha@@@ was down-regulated in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@- and @SPECIES_49577 @@@C. speciosus@@@-treated @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Bakhshwin D, Faddladdeen KAJ, Ali SS, Alsaggaf SM, Ayuob NN. Nanoparticles of Costus speciosus Ameliorate Diabetes-Induced Structural Changes in Rat Prostate through Mediating the Pro-Inflammatory Cytokines IL 6, IL1beta and TNF-alpha Molecules. 2022 Feb 2;27(3):. PMID: 35164292", "BibTeX": "@article{35164292, title={Nanoparticles of Costus speciosus Ameliorate Diabetes-Induced Structural Changes in Rat Prostate through Mediating the Pro-Inflammatory Cytokines IL 6, IL1beta and TNF-alpha}, author={Bakhshwin D and Faddladdeen KAJ and Ali SS and Alsaggaf SM and Ayuob NN}, journal={Molecules}, volume={27}, number={3}}"}}, {"_id": "27378194", "pmid": 27378194, "title": "Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.", "journal": "Crit Rev Oncol Hematol", "authors": ["Gadducci A", "Biglia N", "Tana R", "Cosio S", "Gallo M"], "date": "2016-09-01T00:00:00Z", "doi": "10.1016/j.critrevonc.2016.06.006", "meta_date_publication": "2016 Sep", "meta_volume": "105", "meta_issue": "", "meta_pages": "73-83", "score": 50048.56, "text_hl": "@GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ activation inhibits mRNA translation and proliferation in @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ cells via down-regulation of PI3K/@GENE_AKT1 @GENE_207 @@@Akt@@@/@GENE_MTOR @GENE_2475 @@@mTOR@@@ pathway. Moreover, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ decreases the production of @GENE_INS @GENE_3630 @@@insulin@@@, insulin-like growth factor, @<m>DISEASE_Cytokine_Release_Syndrome</m> @DISEASE_MESH:D000080424 @@@inflammatory cytokines@@@ and @GENE_VEGFA @GENE_7422 @@@vascular endothelial growth factor@@@, and therefore it exerts anti-mitotic, anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ and anti-angiogenetic effects. ", "citations": {"NLM": "Gadducci A, Biglia N, Tana R, Cosio S, Gallo M. Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning. Crit Rev Oncol Hematol. 2016 Sep;105():73-83. PMID: 27378194", "BibTeX": "@article{27378194, title={Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.}, author={Gadducci A and Biglia N and Tana R and Cosio S and Gallo M}, journal={Crit Rev Oncol Hematol}, volume={105}, pages={73-83}}"}}, {"_id": "30935688", "pmid": 30935688, "title": "Metformin alleviates inflammatory response in non-alcoholic steatohepatitis by restraining signal transducer and activator of transcription 3-mediated autophagy inhibition in vitro and in vivo.", "journal": "Biochem Biophys Res Commun", "authors": ["Li YL", "Li XQ", "Wang YD", "Shen C", "Zhao CY"], "date": "2019-05-21T00:00:00Z", "doi": "10.1016/j.bbrc.2019.03.077", "meta_date_publication": "2019 May 21", "meta_volume": "513", "meta_issue": "1", "meta_pages": "64-72", "score": 50047.89, "text_hl": "The current results showed that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ activated autophagy and decreased the mRNA expressions of @<m>DISEASE_Cytokine_Release_Syndrome</m> @DISEASE_MESH:D000080424 @@@inflammatory cytokines@@@, @GENE_IL1B @GENE_16176 @@@IL-1beta@@@, @GENE_IL6 @GENE_16193 @@@IL-6@@@, and @GENE_TNF @GENE_21926 @@@TNF-alpha@@@ via inhibition of the @GENE_STAT3 @GENE_20848 @@@STAT3@@@ mRNA and protein expression. ", "citations": {"NLM": "Li YL, Li XQ, Wang YD, Shen C, Zhao CY. Metformin alleviates inflammatory response in non-alcoholic steatohepatitis by restraining signal transducer and activator of transcription 3-mediated autophagy inhibition in vitro and in vivo. Biochem Biophys Res Commun. 2019 May 21;513(1):64-72. PMID: 30935688", "BibTeX": "@article{30935688, title={Metformin alleviates inflammatory response in non-alcoholic steatohepatitis by restraining signal transducer and activator of transcription 3-mediated autophagy inhibition in vitro and in vivo.}, author={Li YL and Li XQ and Wang YD and Shen C and Zhao CY}, journal={Biochem Biophys Res Commun}, volume={513}, number={1}, pages={64-72}}"}}, {"_id": "29627688", "pmid": 29627688, "title": "Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines.", "journal": "Pharmacol Rep", "authors": ["Dos Santos Guimarães I", "Ladislau-Magescky T", "Tessarollo NG", "Dos Santos DZ", "Gimba ERP", "Sternberg C", "Silva IV", "Rangel LBA"], "date": "2018-06-01T00:00:00Z", "doi": "10.1016/j.pharep.2017.11.007", "meta_date_publication": "2018 Jun", "meta_volume": "70", "meta_issue": "3", "meta_pages": "409-417", "score": 50044.914, "text_hl": "We found that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, in clinical relevant doses, could significantly reduce the mRNA expression of @<m>DISEASE_Cytokine_Release_Syndrome</m> @DISEASE_MESH:D000080424 @@@inflammatory cytokines@@@ and @GENE_NFKB1 @GENE_4790 @@@NF-kappaB@@@ signaling pathway. ", "citations": {"NLM": "Dos Santos Guimarães I, Ladislau-Magescky T, Tessarollo NG, Dos Santos DZ, Gimba ERP, Sternberg C, Silva IV, Rangel LBA. Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines. Pharmacol Rep. 2018 Jun;70(3):409-417. PMID: 29627688", "BibTeX": "@article{29627688, title={Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines.}, author={Dos Santos Guimarães I and Ladislau-Magescky T and Tessarollo NG and Dos Santos DZ and Gimba ERP and Sternberg C and Silva IV and Rangel LBA}, journal={Pharmacol Rep}, volume={70}, number={3}, pages={409-417}}"}}, {"_id": "24791887", "pmid": 24791887, "title": "Metformin inhibits nuclear factor-kappaB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vitro.", "journal": "Chin Med J (Engl)", "authors": ["Gu J", "Ye S", "Wang S", "Sun W", "Hu Y"], "date": "2014-01-01T00:00:00Z", "meta_date_publication": "2014", "meta_volume": "127", "meta_issue": "9", "meta_pages": "1755-60", "score": 50040.355, "text_hl": "We hypothesized that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may ameliorate @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ via @GENE_PRKAA2 @GENE_78975 @@@AMPK@@@ interaction with critical @<m>DISEASE_Cytokine_Release_Syndrome</m> @DISEASE_MESH:D000080424 @@@inflammatory cytokines@@@. ", "citations": {"NLM": "Gu J, Ye S, Wang S, Sun W, Hu Y. Metformin inhibits nuclear factor-kappaB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vitro. Chin Med J (Engl). 2014;127(9):1755-60. PMID: 24791887", "BibTeX": "@article{24791887, title={Metformin inhibits nuclear factor-kappaB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vitro.}, author={Gu J and Ye S and Wang S and Sun W and Hu Y}, journal={Chin Med J (Engl)}, volume={127}, number={9}, pages={1755-60}}"}}]}